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DNA demethylation plays a central role during development and in adult physiology. Different me-
chanisms of active DNA demethylation have been established. For example, Growth Arrest and DNA
Damage 45-(GADD45) and Ten-Eleven-Translocation (TET) proteins act in active DNA demethylation but
their functional relationship is unresolved. Here we show that GADD45a physically interacts – and
functionally cooperates with TET1 in methylcytosine (mC) processing. In reporter demethylation GAD-
D45a requires endogenous TET1 and conversely TET1 requires GADD45a. On GADD45a target genes TET1
hyperinduces 5-hydroxymethylcytosine (hmC) in the presence of GADD45a, while 5-formyl-(fC) and
5-carboxylcytosine (caC) are reduced. Likewise, in global analysis GADD45a positively regulates TET1
mediated mC oxidation and enhances fC/caC removal. Our data suggest a dual function of GADD45a in
oxidative DNA demethylation, to promote directly or indirectly TET1 activity and to enhance subsequent
fC/caC removal.
& 2015 The Authors. Published by Elsevier B.V. on behalf of International Society of Differentiation This is
an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
DNA methylation at the C5 position of cytosine (mC) is a well-
characterized epigenetic mark in higher eukaryotes (reviewed
in Bird (2002), Deaton and Bird (2011), Hackett and Surani (2013)
and Jones and Takai (2001)). mC typically confers transcriptional
silencing within gene regulatory regions and propagates this si-
lenced state to daughter cells. DNA methylation can be very dy-
namic e.g. during epigenetic reprogramming, early embryonic
development and cellular differentiation (reviewed in Messersch-
midt et al. (2014), Niehrs (2009), Williams et al. (2012) and Wu
and Zhang (2010)). During these phases active DNA demethylation,
the enzymatic removal of mC, is crucial to shape the epigenetic
signature in order to activate key developmental genes (reviewed
in Guo et al. (2011a), Messerschmidt et al. (2014), Niehrs and
Schäfer (2012), Pastor et al. (2013), Schäfer (2013) and Wu and
Zhang (2010)). In animals, three main mechanisms of active DNA
demethylation have been proposed: DNA demethylation (i) byw.isdifferentiation.org)
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äfer).nucleotide-excision repair (NER; Barreto et al., 2007), (ii) by base-
excision repair (BER) upon mC deamination by AID (Activation
Induced Deaminase; Cortellino et al., 2011; Morgan et al., 2004),
and (iii) by mC oxidation mediated by the Ten-Eleven Transloca-
tion (TET) family enzymes followed by BER (Maiti and Drohat,
2011; Shen et al., 2013; Tahiliani et al., 2009).
A regulatory protein family in NER- and BER-based DNA de-
methylation is GADD45 (Growth Arrest and DNA Damage Protein
45a,-b,-g). GADD45 proteins are devoid of any obvious enzymatic
activity and act as adapters between demethylation target genes
and the DNA repair machinery. For example, GADD45a binds to
distinct genomic loci via the H3K4me3 reader ING1b (Schäfer
et al., 2013), the RNA polymerase cofactor TAF12 (Schmitz et al.,
2009), or the lncRNA TARID (Arab et al., 2014) to recruit DNA re-
pair enzymes such as the 3′-NER endonuclease XPG (Barreto et al.,
2007; Le May et al., 2010; Schmitz et al., 2009), the BER enzyme
Thymine DNA Glycosylase TDG (Arab et al., 2014; Cortellino et al.,
2011; Li et al., 2015), and AID (Cortellino et al., 2011; Rai et al.,
2008).
An important question is whether GADD45 also interacts with
TET-mediated, oxidative DNA demethylation. TET dioxygenases
iteratively oxidize the methyl group at C5 to yield 5-hydro-
xymethyl-(hmC) (Kriaucionis and Heintz, 2009; Tahiliani et al.,iety of Differentiation This is an open access article under the CC BY-NC-ND license
S. Kienhöfer et al. / Differentiation 90 (2015) 59–68602009), 5-formyl-(fC) (Maiti and Drohat, 2011) and 5-carbox-
ylcytosine (caC) (He et al., 2011; Maiti and Drohat, 2011). caC can
be decarboxylated by bacterial and mammalian C5-DNA methyl-
transferases in vitro (Liutkeviciute et al., 2014). In vivo however,
only TDG mediated excision of fC and caC has been shown to ac-
complish DNA demethylation. The resulting abasic site is pro-
cessed by BER to incorporate unmethylated C (Cortellino et al.,
2011; He et al., 2011; Maiti and Drohat, 2011). Recently it has been
shown that GADD45a enhances TDG mediated removal of fC and
caC (Li et al., 2015). Thus, TDG is a common component of both,
TET- and GADD45 mediated DNA demethylation. Together with25
55
300
250 HA-TET1
myc-GADD45a
Tubulin
IP
710
700
690
680
670
0.1 1 10
Concentrati
GADD45a binding to
TET1CD
BSA
IgG
660
Kd = 549
Fig. 1. GADD45a directly binds TET1. (A) Western blot analysis of co-immunoprecipitatio
HA-TET1 and myc-GADD45a. α-Tubulin was used as speciﬁcity control. Input shows 5% o
Ligation Assay (PLA) in HEK293T cells transiently transfected as indicated. Scale bar,
combinant GADD45a to TET1CD or the negative controls BSA and IgG. Concentration of GA
and IgG were tested (0.1 nM to 5 mM). Each measurement point represents the mean othe ﬁnding that GADD45a and TDG are required for TET mediated
demethylation of TCF21 (Arab et al., 2014) this raises the question,
if Gadd45a may directly interact with TET enzymes.
Here we show that GADD45a and TET1 directly bind each other.
Moreover, GADD45a positively regulates TET1 induced mC oxida-
tion and the two proteins require each other for reporter de-
methylation. Furthermore, GADD45a reduces fC and caC levels,
both gene-speciﬁcally as well as globally. Our data corroborate a
close link between the GADD45a- and TET1-mediated DNA de-
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We ﬁrst tested by three independent approaches if GADD45a- and
TET-proteins physically interact. First, in co-immunoprecipitation
(Co-IP) experiments using overexpressed tagged proteins, both full-
length TET1 as well as TET-catalytic-domain-only (TET1CD) bound
GADD45a (Fig. 1A; Supplement Fig. 1A). Second, we used in-situ
Proximity Ligation Assay (PLA), in which protein–protein interactions
are visualized as ﬂuorescent speckles by rolling-circle ampliﬁcation
(Söderberg et al., 2006). PLA of HA-TET1 with itself (self-PLA) detected
the protein expectedly in the nucleus (Fig. 1B; Tahiliani et al., 2009).
Self-PLA of myc-GADD45a showed both cytoplasmic and nuclear
staining, consistent with the reported bimodal GADD45a distribution
(Fig. 1C; Fayolle et al., 2006). PLA between ectopic GADD45a and TET1
showed robust nuclear staining (Fig. 1D), while no signal was obtained
for the control protein NFYC with TET1 (Fig. 1E). Third, to assess di-
rectness of this interaction, we performed Microscale Thermophoresis
(MST) binding assays with recombinant proteins. GADD45a speciﬁ-
cally bound TET1CD, but not control proteins (BSA, IgG; Fig. 1F). The
apparent Kd was in the high nanomolar range (0.55 μM) and com-
parable to the Kd of GADD45a self-binding (0.57 μM; Supplement
Fig. 1B). This apparently moderate afﬁnity is likely an underestimate,
since the active fraction of both recombinant proteins is probably less
than 100%, notably for GADD45a after covalent modiﬁcation with
ﬂuorescent dye. Taken together, we conclude that GADD45a and TET1
directly interact.
We next tested for functional cooperation of GADD45a and
TET1 in reporter plasmid demethylation, an assay by which the
demethylating activity of both proteins can be monitored (Barreto
et al., 2007; Guo et al., 2011b; Schäfer et al., 2013, 2010). Expres-
sion of GADD45a and TET1 both reduced HpaII resistance of an in
vitro methylated oct4TK-GFP reporter plasmid, i.e. they restored
unmodiﬁed cytosine (Fig. 2A), as expected. Co-expression of
GADD45a further enhanced TET1-mediated demethylation
(Fig. 2A) without affecting TET1 protein levels (Supplement
Fig. 2A). Notably, a catalytically inactive TET1 mutant (TET1CI) ac-
ted dominant negative and impaired GADD45a induced DNA de-
methylation (Fig. 2A), eventually competing with endogenous
TET1 protein or TET1 interactors.
TET1 carries out iterative oxidation of mC and we aimed to
dissect the role of GADD45a in this progression in a time course
experiment following transfection. Over the course of 48 h, mC
was progressively replaced by unmodiﬁed C upon GADD45a or
TET1 expression (Fig. 2B). Combination of TET1 with GADD45a
again led to enhanced DNA demethylation, and this became ap-
parent at 30 h and 48 h after transfection. To analyze the under-
lying mode for this enhanced demethylation we quantiﬁed hmC
and fC/caC at the demethylated CpG of the reporter using qPCR
following MspI restriction on T4 β-glucosyltransferase (β-GT)
treated plasmid DNA (Ito et al., 2011; Kinney et al., 2011). TET1
mediated demethylation was accompanied by a rise in hmC and
fC/caC levels, as expected (Fig. 2C and D). Interestingly, GADD45a
co-expression enhanced hmC at early- and reduced it at late time
points (Fig. 2C). The late-phase hmC reduction by GADD45a cannot
be explained by impairment of TET1 activity, given the enhanced
net demethylation upon GADD45a-TET1 combination (Fig. 2B). The
bimodal kinetics rather suggests that GADD45a promotes not only
TET1 activity to produce hmC, but also enhances its processivity to
proceed with fC/caC formation, as TET1 tends to stop oxidation at
the level of hmC (Lister et al., 2013; Tahiliani et al., 2009; Wu et al.,
2014). fC/caC levels did not accumulate but were reduced by
GADD45a at all late time points (Fig. 2D). This is consistent with
the observation that TDG excision of fC/caC is also enhanced by
GADD45a (Li et al., 2015). Hence, the data point to a dual role of
GADD45a. First, it promotes the iterative oxidation of mC by TET1
and second, GADD45a enhances the TDG removal of fC/caC,thereby promoting DNA demethylation.
To further analyze the interaction of GADD45a and TET1, we
performed loss of function experiments. GADD45a mediated DNA
demethylation was strongly impaired by siRNA mediated knock-
down of TET1 (Fig. 2E). Conversely, TET1 triggered demethylation
was fully dependent on endogenous GADD45a (Fig. 2F), while
TET1 protein levels remained unaffected (Supplement Fig. 2B).
These results indicate that GADD45a and TET1 not only cooperate
in reporter demethylation, but also require each other.
The previous experiments relied on ectopic expression of
GADD45a and TET1. Therefore, we next analysed the endogenous
proteins. We observed previously that the oct4TK-GFP reporter is
demethylated cell-intrinsically upon transfection in HEK293T cells
(Barreto et al., 2007; Schäfer et al., 2013, 2010; see also Fig. 2A and
B). This endogenous demethylation is impaired by knockdown of
either GADD45a or TET1, whereas siTET2 and siTET3 showed no
effect (Fig. 2G; see Supplement Fig. 2C for knockdown). Hence, this
endogenous reporter DNA demethylation requires both, GADD45a
and TET1, but not TET2 or TET3.
We extended our analysis from reporter genes to endogenous
GADD45a target genes. Together with its cofactor, the histone
reader ING1b, GADD45a activates a distinct set of methylation-
silenced genes including TCEAL7, DHRS2 and MAGEB2 in HEK293T
cells (Schäfer et al., 2013). These GADD45a targets were also in-
duced by TET1 in a dose-dependent manner (Fig. 3A). GADD45a-
TET1 co-expression led to synergistic gene activation (Fig. 3A),
without affecting unrelated control gene expression (Supplement
Fig. 3A) or TET1 protein levels (Supplement Fig. 3B). This synergy
was speciﬁc for catalytically active, full-length TET1 as GADD45a
neither cooperated with the TET1-catalytic domain-only (TET1CD)
variant, nor the TET1CI mutant (Fig. 3A-B). The lack of
TET1CD-GADD45a cooperation cannot be explained by the lack of
protein interaction as GADD45a still binds TET1CD in MST-binding
assays and Co-IP experiments (Fig. 1F, Supplement Fig. 1A). The
results rather indicate a critical role of the TET1 N-terminus for
transcriptional induction of GADD45a targets.
TET proteins can regulate transcription not only by active DNA
demethylation but also by recruitment of the O-linked N-acet-
ylglucosamine transferase (OGT) (Chen et al., 2013; Shi et al.,
2013). However, treatment even with a high dose of the OGT in-
hibitor alloxan (Konrad et al., 2002) did not affect target gene
activation by TET1 and GADD45a (Supplement Fig. 3C), making an
involvement of O-GlcNAcylation in this process unlikely. In con-
trast, the dioxygenase activity of TET1 was required for synergistic
gene activation (Fig. 3B). Therefore, we assayed the formation of
hmC and fC/caC within four MspI sites in the TCEAL7 locus (Fig. 3C
and D) where GADD45a is binding (Supplement Fig. 4A and
Schäfer et al., 2013). After 24 h of TET1 expression, hmC formed at
all CpGs analyzed (Fig. 3C). Interestingly, hmC at promoter prox-
imal sites (78 and þ34 relative to the transcription start site)
was further enhanced by GADD45aþTET1 and appeared pre-
cociously after 14 h. This result supports the model that GADD45a
facilitates CpG oxidation by TET1. TET1 induced fC/caC pre-
dominantly at promoter proximal sites, which was once again
reduced by GADD45a (Fig. 3D), paralleling the ﬁndings in reporter
analysis (Fig. 2D). These results support that synergistic target
gene activation by active TET1 and GADD45a is accompanied by
enhanced hmC formation in proximal CpGs and overall reduced fC/
caC levels in the TCEAL7 locus. However, while the relative changes
of induced hmC and fC/caC at the CpG sites analyzed were sig-
niﬁcant, their absolute levels did not exceed 5% and 1.6%, respec-
tively. This suggests that the strong gene activation stems from
only a small subfraction of the cells responding. Consistent with
this interpretation, synergistic TCEAL7 gene activation and hmC
production by TET1 and GADD45a were not accompanied by sig-
niﬁcant TCEAL7 promoter demethylation, as assayed by HpaII
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S. Kienhöfer et al. / Differentiation 90 (2015) 59–68 63resistance, even at 48 h after transfection (Supplement Fig. 3D and
data not shown).
Since the results pointed to a dual role of GADD45a-promoting
TET1 activity and removing fC/caC-we determined global levels of
oxidized mC derivatives by quantitative SID-LC-MS/MS (Stable-
Isotope Dilution Liquid Chromatography tandem Mass Spectro-
metry) (Liu et al., 2013; Pfaffeneder et al., 2014; Tsuji et al., 2014).
Full-length TET1 or TET1CD strongly induced hmC, fC, and caC in
HEK293T cells (Fig. 4A–D), as expected. Combination of GADD45a
with TET1 led to a mild increase in hmC (Fig. 4B), whereas GAD-
D45a alone had no effect (Supplement Fig. 4B). GADD45a co-ex-
pression with TET1 reduced fC and caC levels (Fig. 4C and D),
consistent with the reporter- (Fig. 2C) and gene-speciﬁc analyses
(Fig. 3D), as well as a recent report (Li et al., 2015). Notably, this fC/
caC reduction was restricted to combined expression of GADD45a
with TET1 full-length protein, but not TET1CD (Fig. 4C and D).
These results again support the notion that the increase in hmC
and the decrease of fC/caC are two distinct functions of GADD45a,
the former requiring the TET1 C-terminal catalytic domain, the
latter the TET1 N-terminus.
If GADD45a stimulates TET1 activity, its knockdown should
impair TET1 mediated mC oxidation. Therefore, we combined TET1
expression with siGADD45a. Depletion of GADD45a reduced hmC
formation by TET1 (Fig. 4E) without affecting TET1 protein level
(Supplement Fig. 2B). The concomitant fC/caC reduction in this
context may likely be a consequence of the hmC reduction. Taken
together, our data support a model whereby GADD45a positively
regulates TET1 activity and enhances fC/caC removal.3. Discussion
A major unanswered question in DNA demethylation is the
relationship of the different pathways proposed. Our results pro-
vide the ﬁrst direct evidence that GADD45a and TET1 mediated
DNA demethylation are connected and interdependent. The results
support a dual role of GADD45a in TET1 mediated DNA de-
methylation and we propose that this reﬂects GADD45a binding
and modulation of the two key enzymes in oxidative DNA de-
methylation, TET1 and TDG. First, GADD45a binds TET1 and po-
sitively regulates its activity, thereby enhancing mC oxidation.
Elucidating the mechanism of TET1 activation by GADD45a is a
highly interesting question to be addressed in future studies, and it
may involve e.g. more effective TET1 recruitment to target CpGs,
TET1 conformational change, or recruitment of cofactors conferred
by GADD45a binding. Second, GADD45a reduces fC and caC levels
and we propose that this occurs via TDG: fC/caC removal by the
glycosylase TDG is well-established and GADD45a directly binds
TDG (Arab et al., 2014; Cortellino et al., 2011; Li et al., 2015). Im-
portantly, a recent study demonstrated that GADD45a promotes
processing of fC/caC by TDG by an unknown mechanism (Li et al.,
2015). This study also showed that knockout of both Gadd45a and
Gadd45b from mouse ES cells leads to hypermethylation ofFig. 2. GADD45a promotes TET1-mediated mC oxidation and reporter DNA demethylat
thylation sensitive PCR. (A) HEK293T cells were transfected with oct4TK-GFP along with
Plasmid DNA was recovered 48 h after transfection and subjected to HpaII restriction dig
control; TET1CI, TET1 catalytically inactive mutant. Bar graphs represent the mean of bio
derivatives during oct4TK-GFP reporter demethylation analyzed by modiﬁcation-sensitive
points after transfection. mC and its oxidized derivatives were analyzed using qPCR follo
control treated plasmid DNA. In (B), % modiﬁed cytosine (mCþhmCþ fCþcaC) is displaye
resistance following β-GT treatment and MspI resistance in control treated DNA (with
treated as in (A), but pre-transfected with the indicated siRNAs 24 h before DNA transfec
cells were transfected with oct4TK-GFP without any effector protein with the indicated
was recovered 72 h after siRNA and 48 h after oct4TK-GFP transfection. HpaII cleavage
represent the mean of biological triplicates (n¼3) with error bars7SD. p-Values: (*)
material section.speciﬁc genomic loci, many of which are also targets of TDG.
Hence, GADD45a may function as a bridging protein between TET1
and TDG, thereby physically coupling mC oxidation with repair.
Although the data suggest that GADD45a boosts TET1 mediated
DNA demethylation, global mC levels were not affected. This is
expected since the bulk of mC arises from constitutively methy-
lated repetitive elements, which mask gene-speciﬁc effects of
GADD45a (reviewed in Niehrs and Schäfer (2012) and Schäfer
(2013)). Importantly, the functional cooperation between TET1 and
GADD45a may explain the previously observed co-requirement of
Gadd45 and Tet1 for demethylation of a number of genes, in-
cluding Bdnf IX, Fgf-1b in mouse brain (Guo et al., 2011b; Ma et al.,
2009), TCF21 in cancer cells (Arab et al., 2014), and Oct4- and
Nanog-reporters in embryonic stem (ES) cells (Sabag et al., 2014).
TET1 has been implicated in both, gene activation and gene
repression. In ES cells, loss of Tet1 leads to gene up- and down-
regulation (Williams et al., 2012; Wu et al., 2011; Xu et al., 2011).
Similarly, in HEK293T cells, TET1 represses and activates a number
of genes, however mostly independent of TET1 catalytic activity
(Jin et al., 2014). For gene activation with GADD45a the TET1 di-
oxygenase activity is required (Fig. 3A and B). This supports that
GADD45a can engage TET1 for epigenetic gene activation, e.g. by
targeting TET1 to speciﬁc loci, bridging TDG, or by recruiting co-
factors. The fact that transcriptional activation as well as enhanced
fC/caC removal are dependent on the TET1 N-terminus (Fig. 4B)
suggests that fC/caC removal might be crucial for transcriptional
activation. This is in line with the observation that a single fC or
caC stalls RNA polymerase II in vitro (Kellinger et al., 2012).
The link between GADD45a and TET1 raises new questions.
What is the mechanism by which GADD45a stimulates TET1 ac-
tivity and fC/caC removal by TDG? Does GADD45a regulate the
pattern of hmC, fC and caC deployment during development? Does
combined knockout of Gadd45a and Tet1 affect development in
mice? These questions and the greater physiological signiﬁcance
of the GADD45a-TET1 interaction can now be addressed using e.g.
double-mutant mice.4. Material and methods
4.1. Tissue culture, transfection, siRNA treatment
HEK293T cells were grown at 37 °C in 10% CO2 in Dulbecco's
Modiﬁed Eagle's Medium (DMEM), 10% fetal calf serum, 2 mM L-
Glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. Plas-
mid DNA was transfected using X-tremeGENE 9 at a DNA:X-tre-
meGENE ratio of 1:3. 40 nM stealth siGADD45a (Invitrogen) or
Dharmacon Smart pools were transfected using Lipofectamine
2000 (Invitrogen) or Dharmafect (Dharmacon) 24 h prior to DNA
transfection. For OGT inhibition, 10 mM alloxan was added after
transfection and refreshed after 24 h, prior to harvesting after
48 h.ion. (A–G) Methylation analysis of in vitro methylated oct4TK-GFP reporter by me-
empty vector (Ctrl), GADD45a (G45a) or TET1 expression constructs as indicated.
est and qPCR. HpaII resistance reﬂecting the fraction of modiﬁed C is displayed. Ctrl,
logical triplicates (n¼3) with error bars7SD. (B–D) Kinetics of mC and its oxidized
qPCR. Cells were treated as in (A) and plasmid DNAwas recovered at indicated time
wing HpaII or MspI restriction digest on T4 β-glucosyltransferase (β-GT) treated or
d as % HpaII resistance. (C) and (D) display % hmC and % fC/caC determined by MspI
out β-GT), respectively. Error bars indicate7SD (n¼3). (E, F) HEK293T cells were
tion. HpaII resistance reﬂecting the fraction of modiﬁed C is displayed. (G) HEK293T
siRNAs, whereby “mock” represents transfection reagent only. oct4TK-GFP plasmid
is displayed as % demethylation, reﬂecting formation of unmodiﬁed C. Bar graphs
po0.05; (**) po0.01; (***) po0.001. Complete list of p-values in Supplementary
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caC. Bar graphs represent the mean of biological triplicates (n¼3) with error bars as7SD. p-Values: (*) po0.05; (**) po0.01; (***) po0.001. Complete list of p-values (A–D)
in supplementary material section.
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Fig. 4. GADD45a enhances hmC formation by TET1 and reduces global fC and caC levels. (A–E) SID-LC-MS/MS analysis of mC and its oxidized derivatives in HEK293T cells
transiently transfected with empty vector (Ctrl), GADD45a (G45a), and increasing doses of TET1 or its catalytic domain only (TET1CD) (A–D). For (E), 24 h prior to DNA
transfection, cells were transfected with control or GADD45a speciﬁc siRNA and harvested 48 h after DNA transfection. Bar graphs represent the mean of biological replicates
(for A–D n¼3, for E n¼4) with error bars as7SD. p-Values: (*) po0.05; (**) po0.01; (***) po0.001. Complete list of p-values (A–E) in Supplementary material section. N/D,
no data.
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Flag-HA-TET1 was from Addgene (ID 49792; FH-TET1-pEF). The
catalytically inactive human TET1H1672Y/D1674A mutation has been
described (Guo et al., 2011b). The point mutation was introduced
in the HxD motif using the QuikChange II XL Site-Directed Muta-
genesis Kit (Agilent Technologies) using the following primers:
c5519t_a5526c antisense, 5′-ttattcatgttgtgaatggccctgtagggatgag-
cacagaagtc-3′ c5519t_a5526c sense; 5′-gacttctgtgctcatccctacagggc-
cattcacaacatgaataa-3′. Flag-TET1 catalytic domain (Flag-TET1CD,
aa1416-2136) was PCR ampliﬁed from Flag-HA-TET1 and sub-
cloned into pCS2-2xFlag expression construct. Oct4TK-GFP re-
porter, human pHA-GADD45a and mouse myc-Tet2 expression
plasmids have been described (Barreto et al., 2007; Ko et al., 2010),
respectively. Human GADD45a and NFYC coding sequences were
PCR ampliﬁed and cloned into pCS2þ-myc to express N-termin-
ally myc-tagged fusion proteins. Mouse anti-alpha-Tubulin, anti-ﬂag M2, and anti-myc 9E10 were from Sigma Aldrich, rabbit anti-
GADD45a from Santa-Cruz, rabbit anti-HA and IgG control from
Abcam.
4.3. DNA methylation analysis and T4 β-glucosyltransferase (β-GT)
treatment
Methylation-sensitive PCR (MS-PCR) was performed as de-
scribed (Schäfer et al., 2010). Brieﬂy, HEK293T cells were trans-
fected with in vitromethylated oct4TK-GFP reporter and/or effector
expression plasmids. Plasmid DNA or genomic DNA (gnDNA) was
recovered 48 h after transfection or at indicated time points using
DNeasy Blood & Tissue kit (Qiagen). Plasmid DNA was split into
two parts and digested with either methylation-sensitive HpaII
restriction enzyme or PvuII (unrelated control enzyme to fragment
the genomic DNA) for 3 h. Via qPCR and the Roche Absolute
quantiﬁcation software tool we determined the arbitrary
S. Kienhöfer et al. / Differentiation 90 (2015) 59–6866concentrations, taking into account the PCR-efﬁciency of each in-
dividual primer obtained by standard-curve measurements. HpaII
resistance in % was determined from the ratio of HpaII digested
versus control digested DNA and represents the fraction of mod-
iﬁed cytosine residues (mCþhmCþfCþcaC). T4 β-glucosyl-
transferase (β-GT) treatment was performed according to manu-
facturer's instructions (NEB EpiMark Kit). Brieﬂy, reporter plasmid
or gnDNA was split into two parts and incubated with or without
β-GT for 16 h at 37 °C. Both fractions were again split and digested
with PvuII (control) or MspI and analyzed by qPCR. Primer se-
quences are listed in Supplementary information. MspI restriction
is blocked by fC and caC (Ito et al., 2011). Hence, the ratio of MspI
digested vs PvuII digested DNA reﬂects the combined fraction of
fC/caC. β-GT treatment speciﬁcally glucosylates hmC, resulting in
MspI resistance (Kinney et al., 2011). The ratio of MspI digested vs
PvuII digested DNA (both þβ-GT) thus reﬂects the combined
fraction of hmC/fC/caC. Substraction of fC/caC values (β-GT) from
MspI resistant fraction (þβ-GT) results in % hmC.
4.4. Co-immunoprecipitation (Co-IP)
48 h after transient TET1 and GADD45a transfection, HEK293T
cells were lysed (150 mM NaCl, 20 mM Tris pH 7.5, 2 mM EDTA,
10% glycerol, and cOmplete Mini Protease Inhibitor Cocktail
(Roche)) and needle-syringe-homogenized. Following pre-clearing
of the lysate by centrifugation and incubation with Agarose G
beads (Roche) for 1 h at 4 °C, lysates were incubated on a rotating
wheel over night at 4 °C with speciﬁc antibody or IgG as control.
2 h after addition of the beads and incubation at 4 °C on a rotating
wheel, beads were washed 3 times in lysis buffer and protein was
eluted with 4 Laemmli buffer containing ß-Mercaptoethanol.
For Western blot analysis, 5% of input was compared to 1/3 of the
Co-IP eluate.
4.5. Proximity Ligation Assay (PLA)
For visualization of protein–protein interaction in situ, Proxi-
mity Ligation Assay (PLA) was performed according to manufac-
turer's instructions (Duolink using PLA Technology, Sigma). Brieﬂy,
48 h after transient HA-TET1 and/or myc-GADD45a and myc-NFYC
(control protein) transfection, HEK293T cells were ﬁxed in 100%
MeOH (Sigma) for 10 min at 20 °C, permeabilized with 0.5%
TritonX100 (Sigma) for 10 min, blocked and incubated with pri-
mary antibodies anti-HA (Abcam) and anti-myc (Sigma) (both di-
luted 1:1000) overnight at 4 °C. Then, cells were incubated with
respective secondary antibodies (Duolink In Situ PLA Probes Anti-
Mouse and Anti-Rabbit both PLUS and MINUS, SIGMA) followed by
a ligation and subsequent ampliﬁcation step to visualize protein
interaction by red ﬂuorescence signals (Duolink In Situ Detection
Reagents Red, Sigma). To visualize individual proteins by Self-PLA,
the respective primary antibody was combined with two sec-
ondary antibodies (PLA probes both PLUS and MINUS). Nuclei were
counterstained by DAPI-containing mounting medium (Duolink In
Situ Mounting Medium with DAPI, Sigma) and analysis was per-
formed using a TCS SP5 confocal microscope (Leica) and 63 oil
immersion objective lens. The speckles are likely limited to a
fraction of cells due to incomplete transfection efﬁciency.
4.6. Microscale Thermophoresis
For binding studies, recombinant GADD45a (puriﬁed from E.
coli), recombinant mouse Tet1 (catalytic domain, Active Motif),
BSA (Sigma) or IgG (Abcam) were used. GADD45a was labeled with
the MonolithTM NT.115 Protein Labeling Kit RED-NHS according to
manufacturer's recommendations. Concentration of labeled GAD-
D45a was kept constant at 50 nM and mixed with increasingconcentrations of Tet1, BSA and IgG (0.1 nM to 5 mM) in a sixteen
step 1:1 dilution series in MST buffer (50 mM Tris–HCl pH 7.6,
150 mM NaCl, 10 mM MgCl2 and 0.05% Tween-20). After 15 min of
incubation at room temperature, samples were transferred into
hydrophilic capillaries and measurements were conducted using a
NanoTemper Monolith NT.115 instrument with 60% MST power
and 60% LED power. Laser-On time was 30 s, Laser-Off time 5 s. The
sigmoidal binding curve ﬁtting was performed according to the
law of mass action using NTAnalysis software provided by Nano-
Temper technologies. No ﬁtting was obtained for GADD45a bind-
ing to the negative controls BSA and IgG.
4.7. RT-qPCR
Total RNA was isolated using Qiagen RNeasy mini kit with on-
column DNase digest (Qiagen). First strand cDNA was generated
using SuperScriptII reverse transcriptase (Invitrogen). Real-Time
PCR was performed in technical duplicates using Roche Light-
Cycler480 probes master and primers (see Supplementary in-
formation for primer sequences) in combination with predesigned
mono-color hydrolysis probes of the Roche Universal probe library
(UPL) or SYBR green. For quantiﬁcation, the Roche LC480 quanti-
ﬁcation software module was used. All values were normalized to
the level of the housekeeping gene Gapdh. Mean values shown
were calculated using the mean value of the qPCR replicates from
independent experiments (nZ3).
4.8. Protein expression and puriﬁcation
E. coli BL21-CodonPlus (DE3)-RIL (Stratagene) was transformed
with expression constructs encoding C-terminally hexahistidin
tagged human GADD45a (pET24b-hGADD45a) and N-terminally
hexahistidin-SUMO-tagged Naegleria gruberi Tet1 (pXC1010)
(Hashimoto et al., 2014). Cultures were grown at 37 °C to an
OD600 of 0.6 and induced with 1 mM isopropyl β-D-thiogalacto-
pyranoside (IPTG, Thermo Scientiﬁc). Protein expression was per-
formed at 16 °C overnight. Pelleted cells were resuspended in lysis
buffer (25 mM HEPES/KOH pH 7.6, 0.5 M NaCl, 40 mM Imidazol)
and lysed by passage through a Constant Systems LTD cell dis-
rupter (1.8 kbar, constant run). Cell debris were pelleted by cen-
trifugation at 38,400g for 30 min and supernatant subjected to a
Ni2þ-charged chelating sepharose Fast Flow column (GE Health-
care). Bound proteins were eluted by a stepwise gradient of imi-
dazol (60–500 mM) in lysis buffer. Fractions containing pure pro-
teins were concentrated by Vivaspin ultraﬁltration devices (GE
Healthare). Concentrations of proteins were determined by Brad-
ford assay (Bio-Rad) using BSA as standard.
4.9. Stable-isotope dilution based Liquid Chromatography tandem
Mass Spectrometry (LC–MS/MS)
The genomic DNA (gnDNA) of HEK293T cells was isolated using
DNeasy blood & tissue kit (Qiagen), ethanol precipitated and dis-
solved in ddH2O. 1 mg of gnDNA was degraded with nuclease P1
(Roche Diagnostics, Mannheim, Germany), snake venom phos-
phodiesterase (Worthington, Lakewood, USA) and alkaline phos-
phatase (Fermentas, St. Leon-Roth, Germany). All oligonucleotides
as well as dC and 5mdC nucleosides were from Sigma Aldrich
(Germany). Modiﬁed cytidine nucleosides, hmdC, fdC, cadC were
purchased from Berry & Associates, Inc. (Dexter, MI). 15N3-dCTP,
15N3-dC, 15N5-dG were from Silantes, GmbH (Munich, Germany).
2H3-5mdC was from TRC, Inc (Toronto, Canada). 15N3-5hmdC,
15N3-5fdC, 15N3-5cadC, were self-synthesized by a series of in vitro
reactions (see Supplementary information). All solutions were
prepared using Millipore quality water (Barnstead GenPure xCAD
Plus, Thermo Scientiﬁc). Quantitative LC–MS/MS analysis of the
S. Kienhöfer et al. / Differentiation 90 (2015) 59–68 67nucleosides was performed using an Agilent 1290 UHPLC system
equipped with ReproSil 100 C18 column (3 mm, 4.6150 mm2,
Jasco GmbH, Groß-Umstadt, Germany) and an Agilent 6490 triple
quadrupole mass spectrometer, coupled with the stable isotope
dilution technique, which allows for accurate quantiﬁcation
(Kellner et al., 2015; Liu et al., 2013; Pfaffeneder et al., 2014; Tsuji
et al., 2014). The details of the procedure are described in Sup-
plementary information.
4.10. Statistical analyses
Data are expressed as mean values7standard deviation (SD) of
biological replicates (nZ3). Two-tailed, unpaired Student's t-test
was used to calculate the level of signiﬁcance. A p-valueo0.05
was considered signiﬁcant. *, po0.05; **, po0.01; ***, po0.001.
Full listing of p-values of the individual experiments is provided in
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